1568
RAPD Analysis of the Endophytic Fungi Random amplified polymor-
Vol. 53, No. 12
(ꢁ)-(2R,3R,4R)-3,4,5,7,3ꢃ,4ꢃ-Hexahydroxyflavan (10): A white powder,
[a]D ꢁ8.4° (cꢂ0.77, in EtOH at 26 °C). IR (KBr) cmꢁ1: 3250, 1628. UV
(EtOH) nm (e): 279 (4200). H-NMR (acetone-d6) d: 3.88 (1H, dd, Jꢂ1.2,
phic DNA (RAPD) analyses of the extracted DNA from 35 endophytic fila-
mentous fungi were performed in a mixture of 50 ng of the DNA template,
5 ml of a primer [either primer-1 (5ꢃ-GTAGACCCGT-3ꢃ) or primer-2 (5ꢃ-
CCCGTCAGCA-3ꢃ)], Ready-To-Go RAPD Analysis Beads (Amersham
Biosciences Corp.) and sterile distilled water to a final volume of 25 ml. The
whole mixture was subjected to thermal cycling programmed for 5 min at
95 °C followed by 45 cycles of 1 min at 95 °C, 1 min at 36 °C, and 2 min at
72 °C. The RAPD products were then loaded on 2.3% agarose gel at 150
volts and 140 mA for 240 min and then stained in ethidium bromide for
20 min. The electrophoresis patterns of the amplified products were visual-
ized under UV light.
Microbial Transformation of (ꢀ)-Catechin (1) by the Endophytic
Fungus Diaporthe sp. The endophytic fungus Diaporthe sp. was inocu-
lated into the glucose–yeast extract–peptone medium (200 ml) and cultivated
for 5 d under shaking at 90 rpm at 27 °C. A solution of (ꢀ)-catechin (1,
20 mg) in MeOH (20 ml) was added to the cultivation medium and shaking
continued for 1 d. The reaction mixture was filtrated to remove the fungus
bodies. The filtrate was extracted with EtOAc and concentrated under re-
duced pressure to give a product (45 mg), which was purified by silica gel
column chromatography (SiO2 10 g, CHCl3 : MeOH : H2Oꢂ65 : 35 : 10 lower
phase) and HPLC (Capcell Pak Phenyl SG-120, H2O) to afford (ꢀ)-
(2R,3S,4S)-3,4,5,7,3ꢃ,4ꢃ-hexahydroxyflavan (6, 9.5 mg, 45%)8,9) and the re-
covered (ꢀ)-catechin (1, 1.7 mg, 8.5%).
1
2.2 Hz, 3-H), 4.75 (1H, d, Jꢂ2.2 Hz, 4-H), 5.00 (1H, br s, 2-H), 5.92 (1H, d,
Jꢂ2.1 Hz, 8-H), 6.03 (1H, d, Jꢂ2.1 Hz, 6-H), 6.80 (1H, d, Jꢂ7.9 Hz, 5ꢃ-H),
6.85 (1H, dd, Jꢂ1.8, 7.9 Hz, 6ꢃ-H), 7.08 (1H, d, Jꢂ1.8 Hz, 2ꢃ-H). 13C-NMR
(acetone-d6) d: 64.6 (4-C), 72.3 (3-C), 75.8 (2-C), 95.4 (8-C), 96.3 (6-C),
103.6 (4a-C), 115.5, 115.6 (2ꢃ-C, 5ꢃ-C), 119.4 (6ꢃ-C), 131.9 (1ꢃ-C), 145.4,
145.5 (3ꢃ-C, 4ꢃ-C), 157.6 (8a-C), 159.2 (5-C), 159.3 (7-C). FAB-MS m/z:
307 [MꢀH]ꢀ. High-resolution FAB-MS m/z: Calcd for C15H15O7: 307.0818
[MꢀH]ꢀ. Found 307.0819.
Microbial Transformation of (ꢁ)-Epicatechin 3-O-Gallate (3) by the
Endophytic Fungus Diaporthe sp. The endophytic fungus Diaporthe sp.
was inoculated into glucose–yeast extract–peptone medium (200 ml) and
shaken at 90 rpm at 27 °C for 5 d. A solution of (ꢁ)-epicatechin 3-O-gallate
(3, 20 mg) in MeOH (20 ml) was added to the medium and shaking contin-
ued for 1 d. After filtration to remove the fungus bodies, the filtrate was ex-
tracted with EtOAc. The EtOAc extract was concentrated under reduced
pressure to give a product (51 mg), which was purified by silica gel column
chromatography (SiO2 10 g, CHCl3 : MeOH : H2Oꢂ65 : 35 : 10 lower phase)
followed by HPLC (Capcell Pak Phenyl SG-120, H2O) to afford (ꢁ)-
(2R,3R,4R)-3,4,5,7,3ꢃ,4ꢃ-hexahydroxyflavan (10, 7.2 mg, 53%) and (ꢁ)-epi-
catechin (2, 1.7 mg, 13%).
Microbial Transformation of (ꢁ)-Epigallocatechin 3-O-Gallate (4) by
the Endophytic Fungus Diaporthe sp. The endophytic fungus Diaporthe
sp. was inoculated in glucose–yeast extract–peptone medium (200 ml) and
cultivated for 5 d under shaking at 90 rpm at 27 °C. A solution of (ꢁ)-epigal-
locatechin 3-O-gallate (4, 20 mg) in MeOH (20 ml) was added to the
medium and then shaken for one more day. The reaction mixture was fil-
trated and the filtrate was extracted with EtOAc. The EtOAc layer was con-
centrated under reduced pressure to give a product (48 mg), which was puri-
fied by silica gel column chromatography (SiO2 10 g, CHCl3 : MeOH : H2Oꢂ
65 : 35 : 10 lower phase) and HPLC (Capcell Pak Phenyl SG-120, H2O) to af-
ford (ꢁ)-(2R,3R,4R)-3,4,5,7,3ꢃ,4ꢃ,5ꢃ-heptahydroxyflavan (12, 6.2 mg, 43%)
and (ꢁ)-epigallocatechin (11, 2.6 mg, 19%).
(ꢁ)-(2R,3R,4R)-3,4,5,7,3ꢃ,4ꢃ,5ꢃ-Heptahydroxyflavan (12): A white pow-
der, [a]D ꢁ16.9° (cꢂ0.69, in EtOH at 24 °C). IR (KBr) cmꢁ1: 3300, 1628.
UV (EtOH) nm (e): 279 (4200). 1H-NMR (acetone-d6) d: 3.90 (1H, dd,
Jꢂ1.2, 3.1 Hz, 3-H), 4.76 (1H, d, Jꢂ3.1 Hz, 4-H), 4.95 (1H, br s, 2-H), 5.93
(1H, d, Jꢂ2.4 Hz, 8-H), 6.03 (1H, d, Jꢂ2.4 Hz, 6-H), 6.61 (2H, s, 2ꢃ-, 6ꢃ-H).
13C-NMR (acetone-d6) d: 64.5 (4-C), 72.3 (3-C), 75.7 (2-C), 95.4 (8-C),
96.3 (6-C), 103.6 (4a-C), 106.9 (2ꢃ-C, 6ꢃ-C), 131.1 (1ꢃ-C), 132.9 (4ꢃ-C),
146.2 (3ꢃ-C, 5ꢃ-C), 157.5 (8a-C), 159.2 (5-C, 7-C). FAB-MS m/z: 323
[MꢀH]ꢀ. High-resolution FAB-MS m/z: Calcd for C15H15O8: 323.0767
[MꢀH]ꢀ. Found 323.0737.
Microbial Transformation of (ꢁ)-Gallocatechin 3-O-Gallate (5) by the
Endophytic Fungus Diaporthe sp. The endophytic fungus Diaporthe sp.
was inoculated into glucose–yeast extract–peptone medium (200 ml). After
cultivation for 5 d under shaking at 90 rpm at 27 °C, a solution of (ꢁ)-gallo-
catechin 3-O-gallate (5, 20 mg) in MeOH (20 ml) was added to the medium
and shaking continued for 1 d. The reaction mixture was filtrated and the fil-
trate was extracted with EtOAc. The EtOAc layer was evaporated in vacuo to
give a product (60 mg), which was purified by silica gel column chromatog-
raphy (SiO2 10 g, CHCl3 : MeOH : H2Oꢂ65 : 35 : 10 lower phase) and HPLC
(Capcell Pak Phenyl SG-120, H2O) to give (ꢁ)-gallocatechin (13, 10.1 mg,
75%).
Treatment of (ꢁ)-Catechin (ent-1) and (ꢀ)-Epicatechin (ent-2) by the
Endophytic Fungus Diaporthe sp. After cultivation of the endophytic
fungus Diaporthe sp. in glucose–yeast extract–peptone medium (200 ml) for
5 d under shaking at 90 rpm at 27 °C, each solution of (ꢁ)-catechin (ent-1,
20 mg) and (ꢀ)-epicatechin (ent-2, 20 mg) in MeOH (20 ml) was individu-
ally added to the medium and shaking continued for 1 d. After filtration of
each reaction mixture, the filtrates were extracted with EtOAc and concen-
trated under reduced pressure to give products (43 mg from ent-1, 48 mg
from ent-2), which were purified by silica gel column chromatography (SiO2
10 g, CHCl3 : MeOH : H2Oꢂ65 : 35 : 10 lower phase) to recover (ꢁ)-catechin
(ent-1, 16 mg, 80%) and (ꢀ)-epicatechin (ent-2, 17 mg, 85%), respectively.
The physicochemical properties of (ꢀ)-(2R,3S,4S)-3,4,5,7,3ꢃ,4ꢃ-hexahy-
1
droxyflavan (6) are given here, since Kristiansen8,9) reported only H-NMR
and UV spectra for 6.
(ꢀ)-(2R,3S,4S)-3,4,5,7,3ꢃ,4ꢃ-Hexahydroxyflavan (6): A white powder,
[a]D ꢀ5.5° (cꢂ0.55, in EtOH at 25 °C). IR (KBr) cmꢁ1: 3300, 1612. UV
(EtOH) nm (e): 280 (4,000). 1H-NMR (acetone-d6: 3.85 (1H, dd, Jꢂ3.7,
9.5 Hz, 3-H), 4.84 (1H, d, Jꢂ9.5 Hz, 2-H), 4.87 (1H, d, Jꢂ3.7 Hz, 4-H), 5.65
(1H, d, Jꢂ2.1 Hz, 8-H), 6.02 (1H, d, Jꢂ2.1 Hz, 6-H), 6.80 (1H, dd, Jꢂ2.2,
7.9 Hz, 6ꢃ-H), 6.81 (1H, d, Jꢂ7.9 Hz, 5ꢃ-H), 6.94 (1H, d, Jꢂ2.2 Hz, 2ꢃ-H).
13C-NMR (acetone-d6) d: 62.8 (4-C), 71.4 (3-C), 77.7 (2-C), 95.2 (8-C),
96.4 (6-C), 103.9 (4a-C), 115.7 (2ꢃ-C, 5ꢃ-C), 120.5 (6ꢃ-C), 131.8 (1ꢃ-C),
145.6 (4ꢃ-C), 145.8 (3ꢃ-C), 157.1 (8a-C), 158.9 (5-C), 159.8 (7-C). FAB-MS
m/z: 307 [MꢀH]ꢀ. High-resolution FAB-MS m/z: Calcd for C15H15O7:
307.0818 [MꢀH]ꢀ. Found 307.0810.
Chemical Transformation of (ꢀ)-(2R,3S)-3,5,7,3ꢂ,4ꢂ-Pentahydroxyfla-
vanone (7) into 8 and 9 A solution of (ꢀ)-(2R,3S)-3,5,7,3ꢃ,4ꢃ-pentahy-
droxyflavanone (7, 80 mg, Wako Pure Chemical Industries Ltd.) in MeOH
(5.0 ml) was treated with ethereal diazomethane for 8 h at 0 °C. The reaction
mixture was worked up in a usual manner to give a product (105 mg), which
was purified by silica gel column chromatography (SiO2 15 g, benzene : ace-
toneꢂ8 : 1) to afford (ꢀ)-3-hydroxy-5,7,3ꢃ,4ꢃ-tetramethoxyflavanone (44
mg, 46%). NaBH4 (3.1 mg) was added to a solution of (ꢀ)-3-hydroxy-
5,7,3ꢃ,4ꢃ-tetramethoxyflavanone (10 mg) in MeOH (3.0 ml) at ꢁ20 °C and
the mixture was stirred for 1.5 h at ꢁ20 °C. The reaction mixture was
poured into H2O and extracted with CHCl3. The CHCl3 extract was washed
with brine and dried over Na2SO4. Removal of the solvent gave a product
(12 mg), which was separated by silica gel column chromatography (SiO2
1 g, benzene : acetoneꢂ5 : 1) to afford (ꢀ)-(2R,3S,4S)-3,4-dihydroxy-
5,7,3ꢃ,4ꢃ-tetramethoxyflavan10) (8, 2.9 mg, 29%) and (ꢀ)-(2R,3S,4R)-3,4-di-
hydroxy-5,7,3ꢃ,4ꢃ-tetramethoxyflavan10) (9, 7.0 mg, 68%).
Methylation of (ꢀ)-(2R,3S,4S)-3,4,5,7,3ꢂ,4ꢂ-Hexahydroxyflavan (6)
(ꢀ)-(2R,3S,4S)-3,4,5,7,3ꢃ,4ꢃ-Hexahydroxyflavan (6, 24 mg) was dissolved in
MeOH (1.0 ml) and treated with ethereal diazomethane for 8 h at ꢁ20 °C.
The reaction mixture was worked up in a usual manner to give a product
(35 mg), which was purified by silica gel column chromatography (SiO2
10 g, benzene : acetoneꢂ5 : 1) to afford (2R,3S,4S)-3,4-dihydroxy-5,7,3ꢃ,4ꢃ-
tetramethoxyflavan (8, 12 mg, 42%), which was identified with 8 prepared
from 7.
Microbial Transformation of (ꢁ)-Epicatechin (2) by the Endophytic
Fungus Diaporthe sp. After cultivation of the endophytic fungus Dia-
porthe sp. in glucose–yeast extract–peptone medium (200 ml) for 5 d under
shaking at 90 rpm at 27 °C, a solution of (ꢁ)-epicatechin (2, 20 mg) in
MeOH (20 ml) was added to the cultivation medium and shaken for one
more day. The reaction mixture was filtrated and the filtrate was extracted
with EtOAc. The EtOAc layer was concentrated under reduced pressure to
give a product (48 mg), which was purified by silica gel column chromatog-
raphy (SiO2 10 g, CHCl3 : MeOH : H2Oꢂ65 : 35 : 10 lower phase) and HPLC
(Capcell Pak Phenyl SG-120, H2O) to afford 10 (8.2 mg, 39%) and the re-
covered (ꢁ)-epicatechin (2, 0.48 mg, 2.4%).
Acknowledgement This work was supported by the “High-Tech Re-
search Center” Project for Private Universities: matching fund subsidy from
the Minister of Education, Culture, Sports, Science and Technology, 2004—
2008.